SOCResources, Inc. (PSE:SOC)

CTI BioPharma Balance Sheet

Financials in millions PHP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	817.16	778.4	764.38	749.3	491.21	599.22
Short-Term Investments	-	-	-	-	187.68	-
Cash & Short-Term Investments	817.16	778.4	764.38	749.3	678.88	599.22
Cash Growth	6.50%	1.84%	2.01%	10.37%	13.29%	7.49%
Accounts Receivable	53.25	34.33	46.32	47.35	54.48	46.43
Other Receivables	9.61	17.48	6.63	5.62	0.96	7.22
Receivables	62.87	51.81	52.95	52.97	55.44	53.65
Inventory	975.09	986.72	1,021	1,070	1,015	1,062
Other Current Assets	36.37	51.13	61.64	64.25	68.72	78.95
Total Current Assets	1,891	1,868	1,900	1,936	1,818	1,794
Property, Plant & Equipment	25.38	26.07	28.29	30.96	33.76	36.57
Long-Term Investments	92.67	96.38	85.64	64.25	84.3	43.87
Long-Term Accounts Receivable	6.19	10.97	18.02	47.94	45.54	32.36
Long-Term Deferred Tax Assets	-	7.25	7.92	16.07	13.86	8.58
Other Long-Term Assets	7.69	5.47	4.37	2.96	8.5	5.73
Total Assets	2,023	2,014	2,044	2,099	2,004	1,921
Accounts Payable	64.25	12.02	14.61	15.03	15.68	14.01
Accrued Expenses	-	10.21	16.14	18.29	16.78	4.41
Current Unearned Revenue	79.84	84.19	160.71	140.43	99.74	130.09
Other Current Liabilities	-	32.6	40.12	45.58	38.89	37.7
Total Current Liabilities	144.09	139.02	231.57	219.33	171.09	186.21
Long-Term Unearned Revenue	35.98	37.67	34.44	174.6	168.87	109.56
Long-Term Deferred Tax Liabilities	3.92	11.17	9.48	6.27	4.87	-
Total Liabilities	191.78	195.65	283.41	409.2	353.86	302.39
Common Stock	601.39	601.39	601.39	601.39	601.39	601.39
Additional Paid-In Capital	72.27	72.27	72.27	72.27	72.27	72.27
Retained Earnings	1,031	1,014	966.68	913.77	882.67	859.39
Treasury Stock	-4.96	-4.96	-4.96	-4.96	-4.96	-4.96
Comprehensive Income & Other	131.92	135.63	125.61	106.93	98.56	90.14
Shareholders' Equity	1,832	1,819	1,761	1,689	1,650	1,618
Total Liabilities & Equity	2,023	2,014	2,044	2,099	2,004	1,921
Net Cash (Debt)	817.16	778.4	764.38	749.3	678.88	599.22
Net Cash Growth	6.50%	1.84%	2.01%	10.37%	13.29%	7.49%
Net Cash Per Share	0.91	0.86	0.85	0.83	0.75	0.66
Filing Date Shares Outstanding	901.92	901.92	901.92	901.92	901.92	901.92
Total Common Shares Outstanding	901.92	901.92	901.92	901.92	901.92	901.92
Working Capital	1,747	1,729	1,669	1,717	1,647	1,607
Book Value Per Share	2.03	2.02	1.95	1.87	1.83	1.79
Tangible Book Value	1,832	1,819	1,761	1,689	1,650	1,618
Tangible Book Value Per Share	2.03	2.02	1.95	1.87	1.83	1.79
Land	-	16.34	16.34	16.34	16.34	16.34
Buildings	-	20.38	20.38	20.38	20.38	20.38
Machinery	-	37.59	37.3	36.9	36.2	34.73
Leasehold Improvements	-	5.82	5.82	5.82	5.72	5.72

Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.